I wore the world's first HDR10 smart glasses TCL's new E Ink tablet beats the Remarkable and Kindle Anker's new charger is one of the most unique I've ever seen Best laptop cooling pads Best flip ...

Shreyas Sen is the Founder and CTO of Quasistatics, Inc. (dba Ixana), which develops Wi-R, a wireless body-area communication technology. He owns shares in the company. How do headphones, toys, ...

Merve Ceylan is a dietitian and health writer with four years of experience writing for companies in the nutrition and health industry. Some foods and drinks can worsen prostate health. Saturated fats ...

Imperial College London investigators compared focal therapy with prostate removal surgery for men with prostate cancer that returned after radiotherapy. Matched analyses estimated 10-year ...

Small fragments of plastic were found in 9 out of 10 patients with prostate cancer, and in higher levels inside tumors than in nearby noncancerous tissue, a new study finds. The small, single-center ...

Throne, a startup based in Austin, has developed a toilet add-on that measures gut health through things like frequency, ...

In a new study, researchers found microplastics deep inside prostate cancer tumors, raising more questions about the role the ubiquitous pollutants play in public health. The findings — which come ...

New formulation of its widely-used U.S. market-leading PSMA PET imaging agent combines thediagnostic performance of PYLARIFY® (piflufolastat F 18) with the potential for la ...

The “ethical hacker” who created the Bluetooth “signal sniffer” being used to try to track Nancy Guthrie’s pacemaker said he created the high-tech tool specifically for the search for the missing ...

Lantheus Holdings recently received FDA approval for PYLARIFY TruVu, an enhanced formulation of its PSMA PET imaging agent designed to improve manufacturing efficiency and geographic reach for ...

A PSMA PET scan found more recurrent prostate cancer at low PSA levels than a standard scan, helping guide more potentially curative treatment decisions. A newer type of prostate cancer scan called 64 ...

Astellas is aiding Vir Biotechnology’s oncology pivot with a $1.7 billion global collaboration focused on a potential best-in-class T-cell engager (TCE) for prostate cancer. Under the leadership of ...